Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Lesalpes29on Feb 01, 2023 6:27am
192 Views
Post# 35258750

RE:RE:RE:RE:RE:RE:RE:RE:Thomaslchim claims to an ONCY director- NOT !

RE:RE:RE:RE:RE:RE:RE:RE:Thomaslchim claims to an ONCY director- NOT !
Noteable wrote: It appears that Thomas E. Ichim is trying to bring as much negative attention to ONCY as he possibly can. Is it because as a licenced (1990) derivative and options trader he has a lingering  short in ONCY that he can't get out of without driving up the price at a time when the prospect of ONCY being acquired in the near foreseeable future is palpable? Yes Very likely the case ..and in concert with a small group of others who've demonstrated that they are the George Santos' of stock message boards, especially the ones which post on ONCY.
Those new or old posters on stocktwits are parhetic. Hope they don't have any negative impact on the SP. Not sure because I was in the impression we were about to move up this week. Stocktwits was relatively calm and instructive but now it's looking like Yahoo board! At least it's probably a good sign, some are in trouble with an heavy naked short position. And they smell positive news to come. GL

<< Previous
Bullboard Posts
Next >>